ES2131224T3 - Uso del formiato de calcio para la fabricacion de preparados de administracion oral. - Google Patents

Uso del formiato de calcio para la fabricacion de preparados de administracion oral.

Info

Publication number
ES2131224T3
ES2131224T3 ES95101172T ES95101172T ES2131224T3 ES 2131224 T3 ES2131224 T3 ES 2131224T3 ES 95101172 T ES95101172 T ES 95101172T ES 95101172 T ES95101172 T ES 95101172T ES 2131224 T3 ES2131224 T3 ES 2131224T3
Authority
ES
Spain
Prior art keywords
manufacture
oral administration
administration preparations
calcium format
format
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95101172T
Other languages
English (en)
Inventor
Ulf Dr Abele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chevita GmbH
Original Assignee
Chevita GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6508909&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2131224(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chevita GmbH filed Critical Chevita GmbH
Application granted granted Critical
Publication of ES2131224T3 publication Critical patent/ES2131224T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

LA INVENCION SE REFIERE A LA UTILIZACION DE FORMIATO DE CALCIO EN COMPOSICIONES PARA APLICACION ORAL EN LA PROFILAXIS Y METAFILAXIS DE FALTA DE CALCIO EN ANIMALES. EL OBJETIVO DE LA PRESENTE INVENCION ES ENCONTRAR UN COMPUESTO DE CALCIO, QUE SEA SABROSO COMO COMPUESTO DE CALCIO CONOCIDO DE ACUERDO CON EL ESTADO TECNOLOGICO, QUE EXCLUYA AMPLIAMENTE IRRITACIONES DE TEJIDO PARCIALMENTE PATOLOGICAS EN EL TRACTO INTESTINAL-ESTOMACAL DE LOS ANIMALES Y MUESTRA UN CONTENIDO EN CALCIO ALTAMENTE SUFICIENTE EN UN VOLUMEN DE PRESENTACION RELATIVAMENTE PEQUEÑO. LA INVENCION SE BASA EN EL CONOCIMIENTO SORPRENDENTE, DE QUE POR MEDIO DE LA UTILIZACION DE FORMIATO DE CALCIO EN COMPOSICIONES ELABORABLES PARA APLICACION ORAL PUEDAN SER EVITADAS LAS DESVENTAJAS CONOCIDAS DE ACUERDO CON EL ESTADO TECNOLOGICO PARA LA PROFILAXIS, TERAPIA Y METAFILAXIS DE APARICIONES DE FALTA DE CALCIO. LA SOLUCION SE REFIERE ESPECIALMENTE DE ACUERDO CON LA INVENCION A LA UTILIZACION DE FORMIATO DE CALCIO EN UN GEL O EN UNA PASTA.
ES95101172T 1994-01-28 1995-01-27 Uso del formiato de calcio para la fabricacion de preparados de administracion oral. Expired - Lifetime ES2131224T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4402544A DE4402544C2 (de) 1994-01-28 1994-01-28 Veterinärmedizinische Verwendung von Calciumformiat in Gel- oder Pastenform

Publications (1)

Publication Number Publication Date
ES2131224T3 true ES2131224T3 (es) 1999-07-16

Family

ID=6508909

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95101172T Expired - Lifetime ES2131224T3 (es) 1994-01-28 1995-01-27 Uso del formiato de calcio para la fabricacion de preparados de administracion oral.

Country Status (6)

Country Link
US (1) US5631289A (es)
EP (1) EP0667152B1 (es)
JP (1) JPH0853348A (es)
AT (1) ATE178792T1 (es)
DE (2) DE4402544C2 (es)
ES (1) ES2131224T3 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4402544C2 (de) 1994-01-28 1996-01-18 Chevita Gmbh Veterinärmedizinische Verwendung von Calciumformiat in Gel- oder Pastenform
AU3434597A (en) * 1996-07-16 1998-02-09 Jorgen Kruuse A/S An orally administrable, paste-like composition for veterinary use, a method for the preparation thereof, and the use of an oily vehicle for the manufacture of such composition
ES2251361T3 (es) 1998-10-30 2006-05-01 Rj Innovation Un metodo de prevencion de hipocalcemia puerperal en animales y composiciones utilizadas en el mismo.
US6355278B1 (en) 1999-03-31 2002-03-12 West Central Cooperative Dry dairy cow supplement
US20020150633A1 (en) * 1999-03-31 2002-10-17 Myron Danzer Dry dairy cow supplement
US6160016A (en) * 1999-12-22 2000-12-12 Wisconsin Alumni Research Foundation Phosphorus binder
CA2395530C (en) * 1999-12-22 2008-07-15 Wisconsin Alumni Research Foundation Calcium formate for use as a phosphorus binder and a dietary supplement
WO2002049657A1 (en) * 2000-12-21 2002-06-27 Massey University Methods and compositions for reducing or preventing onset of milk fever
US9039618B2 (en) * 2003-07-24 2015-05-26 Hewlett-Packard Development Company, L.P. Medical imaging device and method
CN103006698A (zh) 2006-10-10 2013-04-03 威斯康星旧生研究基金会 乳房内乳头密封剂和使用该制剂降低或消除成熟干酪中视觉缺陷的方法
KR20120005497A (ko) * 2009-04-08 2012-01-16 위스콘신 얼럼나이 리서어치 화운데이션 유방내 유두 밀봉 제제 및 이를 사용하여 숙성된 치즈에서 시각적 결함을 감소 또는 제거시키는 방법
FR3025104B1 (fr) * 2014-08-29 2017-11-24 Hy-Nutrition Bolus a liberation immediate
US20230248761A1 (en) * 2022-02-10 2023-08-10 Contract Manufacturing Services, LLC Method for supporting normal blood calcium concentrations in mammals

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7117054A (es) * 1970-12-17 1972-06-20
US4599330A (en) * 1982-05-17 1986-07-08 Hoffmann-La Roche Inc. Method of treating milk fever
US4772467A (en) * 1985-02-19 1988-09-20 Board Of Regents, U T Systems Osteoporosis inhibition by dietary calcium supplementation
US4814177A (en) * 1986-03-18 1989-03-21 Board Of Regents, University Of Texas System Ultradense and more soluble and bioavailable preparations of calcium citrate
US4752479A (en) * 1986-05-27 1988-06-21 Ciba-Geigy Corporaton Multi vitamin and mineral dietary supplement with controlled release bioavailable iron
DE3628249C1 (de) * 1986-08-20 1987-11-26 Degussa Mittel zur Verbesserung des Wachstums und der Futterverwertung bei Schweinen
US4931290A (en) * 1988-09-23 1990-06-05 Domain, Inc. Milk fever prophylactic treatment and composition
DK159807C (da) * 1989-02-27 1992-06-29 Gunnar Kjems Anvendelse af calciumsaltholdige emulsioner til fremstilling af orale midler til forebyggelse eller behandling af calciummangel hos kvaeg, isaer ved kaelvningsfeber
DE4402544C2 (de) 1994-01-28 1996-01-18 Chevita Gmbh Veterinärmedizinische Verwendung von Calciumformiat in Gel- oder Pastenform
WO1996009797A1 (en) * 1994-09-28 1996-04-04 Innovasive Devices, Inc. Suture tensioning device

Also Published As

Publication number Publication date
US5631289A (en) 1997-05-20
DE59505618D1 (de) 1999-05-20
EP0667152A1 (de) 1995-08-16
DE4402544A1 (de) 1995-08-03
JPH0853348A (ja) 1996-02-27
EP0667152B1 (de) 1999-04-14
DE4402544C2 (de) 1996-01-18
ATE178792T1 (de) 1999-04-15

Similar Documents

Publication Publication Date Title
ES2131224T3 (es) Uso del formiato de calcio para la fabricacion de preparados de administracion oral.
ZA895936B (en) Pharmaceutical compositions comprising selected lactobacillus strains
ES554967A0 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
ES2032503T3 (es) Medicamento para la zona de la cavidad bucal. (reserva del art. 167.2 cpe).
NO910213L (no) Fremgangsmaate for fremstilling av orale legemiddelformer av pimobendan.
EP0303915A3 (en) Retinoids for the treatment of skin damaged by light
DK198791A (da) Terapeutiske kombinationer af 3'-azido-3'-desoxythymidin og andre terapeutiske midler
IS4067A (is) PEG-Interferonafleiður, aðferð til framleiðslu þeirra, og notkunar sem lyfja
FI931250A0 (fi) Sulfonamido- och sulfonamidokarbonyl-pyridin-2-karboxylsyraamider och deras pyridin-n-oxider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
ATE90345T1 (de) Bis-naphthalimide, ihre herstellung und verwendung.
DE69715259D1 (de) Infektionsfreie intramammäre tierarzneimittelzusammenstellung
EP0276543A3 (en) Use of buspirone for the improvement of short term memory
DE3875867D1 (de) Kalziumzusaetze.
ATE69167T1 (de) Pharmazeutische zusammensetzung fuer die prophylaxe und die therapie des magengeschwuers.
FI852730A0 (fi) (pyrrol-1-yl) -fenyl-dihydropyridazinoner, deras framstaellning och anvaendning.
EP0331092A3 (en) Alpha-amino-carboxylic-acid derivatives, their preparation and use
FR2576753B1 (fr) Nouvelles compositions pour l'alimentation des animaux
ATE14015T1 (de) Oxazolderivate, ihre herstellung und ihre verwendung.
DE2963010D1 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivatives, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds for promoting growth in certain animals and their manufacture
NO970185L (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
AU4040195A (en) Topical composition containing penciclovir
ATE270098T1 (de) Wirkstoff enthaltende orale oder mucosale zubereitung mit steuerbarer wirkstofffreisetzung und ihre verwendung
SE8500822D0 (sv) Diazepinoindoles, their production and pharmaceutical compositions containing them
DE69719190D1 (de) Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
EP0252033A3 (en) Utilization of the "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) utilizable in therapy for topical usage

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 667152

Country of ref document: ES